SAMSUNG BIOLOGICS CO.,LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 775,000 KRW | +0.65% |
|
-0.77% | +1.97% |
| 04-25 | Samsung Bioepis Granted Approval to Market Autoimmune Treatment in Europe | MT |
| 04-25 | Samsung Biologics Posts Higher Q1 Profit, Sales | MT |
Quotes 5-day view
End-of-day quote Korea S.E.| 2024-04-23 | 2024-04-24 | 2024-04-25 | 2024-04-26 | Today | 2024-04-28 | |
|---|---|---|---|---|---|---|
| Last | 791000 ₩ | 790000 ₩ | 780000 ₩ | 770000 ₩ | 775000 ₩ | 775,000 ₩ |
| Volume | 44 112 | 48 667 | 68 732 | 82 298 | 53 198 | 53 198 |
| Change | -1.37% | -0.13% | -1.27% | -1.28% | +0.65% | +0.65% |
| Opening | 795,000.00 | 799,000.00 | 783,000.00 | 779,000.00 | 775,000.00 | 775,000 |
| High | 800,000.00 | 804,000.00 | 789,000.00 | 780,000.00 | 778,000.00 | 778,000 |
| Low | 789,000.00 | 788,000.00 | 775,000.00 | 769,000.00 | 768,000.00 | 768,000 |
Performance
| 1 day | +0.65% | ||
| 1 week | -0.77% | ||
| Current month | -6.74% | ||
| 1 month | -6.96% | ||
| 3 months | +0.26% | ||
| 6 months | +7.19% | ||
| Current year | +1.97% | ||
| 1 year | -0.77% | ||
| 3 years | -2.02% | ||
| 5 years | +124.31% |
Volumes
marketsDaily volume
53 198
Avg. Volume 20 sessions
48 772
Avg. Volume 20 sessions KRW
37 798 300 000.00
Avg. Volume 20 sessions USD
27 479 364.10
Record volume 1
8 089 601
Record volume 2
7 156 671
Record volume 3
3 037 569
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (KRW)
54 767 580 917 469
Capitalization (USD)
39 816 031 327
Net sales (KRW)
3 695
Net sales (USD)
3
Number of employees
4 284
Sales / Employee (KRW)
1
Sales / Employee (USD)
0
Free-Float
25.25 %
Free-Float capitalization (KRW)
13 831 336 565 260
Free-Float capitalization (USD)
10 055 381 683
Average Daily Capital Traded
0.07%
Highs and lows
1 week
768 000.00
804 000.00
1 month
768 000.00838 000.00
Current year
739 000.00880 000.00
1 year
668 000.00880 000.00
3 years
668 000.001 000 000.00
5 years
241 500.001 000 000.00
10 years
125 500.001 000 000.00
Indicators
Moving average 5 days
781 200.00
Moving average 20 days
795 600.00
Moving average 50 days
811 740.00
Moving average 100 days
786 840.00
Price spread / (MMA5)
+0.80%
Price spread / (MMA20)
+2.66%
Price spread / (MMA50)
+4.74%
Price spread / (MMA100)
+1.53%
STIM
RSI 9 days
37.47
RSI 14 days
39.47
Sector Comparison - Biopharmaceuticals
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| +0.65% | -0.77% | +1.97% | -0.77% | 39.82B | ||
| +0.62% | +2.04% | -4.06% | -8.51% | 86.13B | ||
| -0.80% | +1.27% | +56.59% | +46.70% | 25.23B | ||
| +3.00% | -7.06% | -13.74% | -14.23% | 15.36B | ||
| +0.35% | +2.67% | -8.82% | -8.61% | 11.95B | ||
| +2.49% | +2.00% | -15.66% | -29.71% | 11.6B | ||
| +2.50% | -11.83% | -41.58% | -34.18% | 11.51B | ||
| +0.85% | +7.84% | +6.14% | +12.64% | 8.71B | ||
| +1.53% | +19.73% | -7.02% | +6.14% | 8.12B | ||
| +0.32% | -1.40% | +2.62% | +16.37% | 7.72B | ||
| +1.61% | +4.81% | +79.19% | +305.75% | 6.69B | ||
| +0.14% | +2.71% | -10.00% | +9.59% | 6.59B | ||
| -0.70% | -1.19% | -8.37% | +5.78% | 6.49B | ||
| -3.19% | +1.42% | -19.29% | -41.73% | 6.05B | ||
| +0.76% | +2.72% | -45.33% | -7.39% | 5.41B | ||
| +4.96% | +2.26% | -12.07% | -16.41% | 4.68B | ||
| Average | +1.04% | +2.10% | -2.46% | +15.09% | ||
| Weighted average by Cap. | +0.81% | +1.13% | +0.72% | +5.41% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Monthly variations
Annual change
| 2024 | +1.97% | ||
| 2023 | -7.43% | ||
| 2022 | -9.08% | ||
| 2021 | +9.32% | ||
| 2020 | +90.76% | ||
| 2019 | +12.03% | ||
| 2018 | +4.18% | ||
| 2017 | +145.70% | ||
| 2016 | +4.86% |
- Stock Market
- Equities
- A207940 Stock
- Quotes Samsung Biologics Co.,Ltd.
